Streetbeat News

Stock Prices

EQR

Stifel analyst Simon Yarmak has maintained a Hold rating on Equity Residential (NYSE:EQR) but has lowered the price target from $60 to $59.5.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 6:54 pm

AZN

SNY

The CDC has released over 77,000 additional doses of Beyfortus, an RSV drug developed by Sanofi and AstraZeneca, due to surging demand. Beyfortus was FDA-approved in July for preventing RSV in newborns and infants. The CDC and FDA are working to ensure availability for the rest of the year and early 2024. RSV cases have notably increased, with significant hospitalizations among children under five. Shares of AstraZeneca and Sanofi rose by 0.67% on the news.

Portfolio Pulse from Vandana Singh

November 17, 2023 | 6:47 pm

BTCUSD

ETHUSD

Former FTX US president Brett Harrison discussed the potential approval of Bitcoin ETFs and the impact on Bitcoin's price at a private roundtable. He expressed dissatisfaction with the lack of crypto regulations in the US and compared it to other countries that are further along. Harrison, now CEO of Architect, a financial technologies company, also spoke on the importance of both self-custody and third-party custody in the crypto space.

Portfolio Pulse from Chris Katje

November 17, 2023 | 6:45 pm

NVDA

Wedbush analyst Matt Bryson remains bullish on Nvidia Corp (NASDAQ:NVDA), reiterating an Outperform rating with a $600 price target. Bryson cites strong demand and a supply shortage that is expected to continue into 2024-2025. Despite potential shortfalls in the near term, unfulfilled demand is seen as an opportunity for future shipments. Conversations with the Taiwanese supply chain indicate a surge in AI server builds, benefiting Nvidia. Bryson also notes Nvidia's success in shipping networking technology alongside GPUs and does not see Nvidia's market dominance being challenged soon. He projects Q3 and Q4 revenues and EPS above consensus estimates.

Portfolio Pulse from Anusuya Lahiri

November 17, 2023 | 6:39 pm

GTLB

Barclays analyst Ryan Macwilliams has downgraded GitLab (NASDAQ:GTLB) from Overweight to Equal-Weight and reduced the price target from $65 to $50, indicating a more cautious outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 6:35 pm

AMAT

Applied Materials, Inc. (NASDAQ:AMAT) stock is falling due to a U.S. Department of Justice criminal investigation into potential evasion of export restrictions to China's SMIC. Despite reporting better-than-expected Q4 earnings of $2.12 per share and revenue of $6.72 billion, the Reuters report on the investigation has overshadowed these financial results. The stock has seen more than double its 100-day average trading volume as a result of the news.

Portfolio Pulse from Erica Kollmann

November 17, 2023 | 6:34 pm

VAC

B of A Securities analyst Shaun Kelley has downgraded Marriott Vacations (NYSE:VAC) from Neutral to Underperform and reduced the price target from $125 to $65.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 6:33 pm

TFIN

DA Davidson analyst Gary Tenner downgraded Triumph Financial (NASDAQ:TFIN) from Buy to Neutral and set a price target of $72.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 6:31 pm

STZ

Constellation Brands (NYSE:STZ) has delivered an average annual return of 12.96% over the past 10 years, outperforming the market by 3.34% on an annualized basis. A $100 investment in STZ a decade ago would now be worth $339.89. The company currently has a market cap of $43.09 billion.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 6:30 pm

CCI

Crown Castle (NYSE:CCI) has delivered an average annual return of 11.38% over the past 20 years, outperforming the market. A $100 investment in CCI 20 years ago would be worth $859.39 today. Crown Castle currently has a market cap of $45.41 billion.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 6:30 pm